These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38946053)

  • 1. Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type Lesions.
    Masetto F; Mafficini A; Saka B; Armutlu A; Chatterjee D; Jang KT; Zen Y; Navale P; Fassan M; Bacchi CE; Mattiolo P; Simbolo M; Ruzzenente A; Lawlor RT; Reid M; Basturk O; Adsay V; Scarpa A; Luchini C
    Am J Surg Pathol; 2024 Jul; ():. PubMed ID: 38946053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities.
    Zen Y
    Hum Pathol; 2023 Feb; 132():197-207. PubMed ID: 35697170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal tubulopapillary neoplasms of the bile ducts: identity, clinicopathologic characteristics, and differential diagnosis of a distinct entity among intraductal tumors.
    Pehlivanoglu B; Adsay V
    Hum Pathol; 2023 Feb; 132():12-19. PubMed ID: 35934108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.
    Basturk O; Berger MF; Yamaguchi H; Adsay V; Askan G; Bhanot UK; Zehir A; Carneiro F; Hong SM; Zamboni G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Balci S; Allen P; Ikari N; Takeuchi S; Akagawa H; Kanno A; Shimosegawa T; Morikawa T; Motoi F; Unno M; Higuchi R; Yamamoto M; Shimizu K; Furukawa T; Klimstra DS
    Mod Pathol; 2017 Dec; 30(12):1760-1772. PubMed ID: 28776573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
    Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
    Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma.
    Wen KW; Joseph NM; Srivastava A; Saunders TA; Jain D; Rank J; Feely M; Zarrinpar A; Al Diffalha S; Shyn PB; Graham RP; Drage MG; Kakar S
    Hum Pathol; 2021 Oct; 116():82-93. PubMed ID: 34298064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-Tubulocystic Variant of Intrahepatic Cholangiocarcinoma: Report of a Pediatric Case With Molecular Characterization.
    González IA; Linn RL; Wilkins BJ
    Pediatr Dev Pathol; 2022; 25(6):661-667. PubMed ID: 36031872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.
    Schlitter AM; Jang KT; Klöppel G; Saka B; Hong SM; Choi H; Offerhaus GJ; Hruban RH; Zen Y; Konukiewitz B; Regel I; Allgäuer M; Balci S; Basturk O; Reid MD; Esposito I; Adsay V
    Mod Pathol; 2015 Sep; 28(9):1249-64. PubMed ID: 26111977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.
    Balitzer D; Joseph NM; Ferrell L; Shafizadeh N; Jain D; Zhang X; Yeh M; di Tommaso L; Kakar S
    Mod Pathol; 2019 Oct; 32(10):1486-1494. PubMed ID: 31186529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver.
    Tsui WM; Loo KT; Chow LT; Tse CC
    Am J Surg Pathol; 1993 Feb; 17(2):186-92. PubMed ID: 8422113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
    Churi CR; Shroff R; Wang Y; Rashid A; Kang HC; Weatherly J; Zuo M; Zinner R; Hong D; Meric-Bernstam F; Janku F; Crane CH; Mishra L; Vauthey JN; Wolff RA; Mills G; Javle M
    PLoS One; 2014; 9(12):e115383. PubMed ID: 25536104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraductal tubular neoplasms of the bile ducts.
    Katabi N; Torres J; Klimstra DS
    Am J Surg Pathol; 2012 Nov; 36(11):1647-55. PubMed ID: 23073323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
    Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
    J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary intraductal tubule-forming neoplasm: a whole exome sequencing study of MUC5AC-positive and -negative cases.
    Akita M; Hong SM; Sung YN; Kim MJ; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Histopathology; 2020 Jun; 76(7):1005-1012. PubMed ID: 32181510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases.
    Ulamec M; Skenderi F; Zhou M; Krušlin B; Martínek P; Grossmann P; Peckova K; Alvarado-Cabrero I; Kalusova K; Kokoskova B; Rotterova P; Hora M; Daum O; Dubova M; Bauleth K; Slouka D; Sperga M; Davidson W; Rychly B; Perez Montiel D; Michal M; Hes O
    Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):521-30. PubMed ID: 26447894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.
    Sarungbam J; Mehra R; Tomlins SA; Smith SC; Jayakumaran G; Al-Ahmadie H; Gopalan A; Sirintrapun SJ; Fine SW; Zhang Y; Amin MB; Reuter VE; Chen YB; Tickoo SK
    Mod Pathol; 2019 May; 32(5):701-709. PubMed ID: 30622286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation spectrum associated with metastasis of advanced cholangiocarcinoma.
    Song H; Huang Y; Jiang X
    J Int Med Res; 2022 Jun; 50(6):3000605221102080. PubMed ID: 35726602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.
    Zen Y; Fujii T; Itatsu K; Nakamura K; Konishi F; Masuda S; Mitsui T; Asada Y; Miura S; Miyayama S; Uehara T; Katsuyama T; Ohta T; Minato H; Nakanuma Y
    Mod Pathol; 2006 Sep; 19(9):1243-54. PubMed ID: 16741522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma?
    Nakanuma Y; Tsutsui A; Ren XS; Harada K; Sato Y; Sasaki M
    Int J Hepatol; 2014; 2014():805973. PubMed ID: 24860673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.